Bernd Christensen

Title: Bernd Christensen: Innovator in Pharmaceutical Composition

Introduction

Bernd Christensen is a notable inventor based in Essen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the administration of dienogest for medical purposes. His innovative approach has the potential to impact women's health positively.

Latest Patents

Christensen holds a patent for a method of administering dienogest in high dosages to reduce the body of the breast. This patent describes a method for administering dienogest to women in high dosages, which is at least ten times the effective dosage for inhibiting ovulation. The pharmaceutical composition associated with this method is also detailed in the patent. Furthermore, the method can lead to the retrogression of mastopathic changes in the breast, making dienogest suitable for the prophylaxis of mastopathies. In high dosages, dienogest effectively prevents the formation of mastopathic changes in the breast.

Career Highlights

Bernd Christensen is associated with Jenapharm GmbH & Co. KG, where he has been instrumental in developing innovative pharmaceutical solutions. His work has garnered attention for its potential benefits in women's health, particularly concerning breast health.

Collaborations

Christensen has collaborated with notable colleagues, including Michael Oettel and Claudia Moore. Their combined expertise contributes to the advancement of pharmaceutical research and development.

Conclusion

Bernd Christensen's contributions to the field of pharmaceuticals, particularly through his patent on dienogest administration, highlight his role as an innovator in women's health. His work continues to pave the way for advancements in medical treatments.